NOVA-II: Part 2 study to evaluate the safety and efficacy of OQL011 on VEGF inhibitor-associated hand-foot skin reaction in patients with cancer Meeting Abstract


Authors: Patel, A. B.; Anadkat, M. J.; Marathe, O. S.; Webb, M. L.; Tyler, R. C.; Zhang, W.; Wu, C.; Ju, J.; Tang, H.; Luo, J.; Lacouture, M. E.
Abstract Title: NOVA-II: Part 2 study to evaluate the safety and efficacy of OQL011 on VEGF inhibitor-associated hand-foot skin reaction in patients with cancer
Meeting Title: 2023 ASCO Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 6 Suppl.
Meeting Dates: 2023 Feb 16-18
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-02-20
Language: English
DOI: 10.1200/JCO.2023.41.6_suppl.TPS741
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: TPS741 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mario E Lacouture
    457 Lacouture